Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hypermarcas Operating Margin 2010-2025 | HYPMY

Current and historical operating margin for Hypermarcas (HYPMY) over the last 10 years. The current operating profit margin for Hypermarcas as of March 31, 2025 is 12.54%.
  
Hypermarcas Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2025-03-31 $1.20B $0.18B 15.23%
2024-12-31 $1.38B $0.34B 24.51%
2024-09-30 $1.50B $0.44B 29.27%
2024-06-30 $1.60B $0.50B 31.45%
2024-03-31 $1.63B $0.52B 31.82%
2023-12-31 $1.59B $0.50B 31.78%
2023-09-30 $1.62B $0.53B 32.88%
2023-06-30 $1.57B $0.51B 32.65%
2023-03-31 $1.50B $0.50B 32.96%
2022-12-31 $1.46B $0.48B 32.99%
2022-09-30 $1.35B $0.45B 33.09%
2022-06-30 $1.27B $0.42B 33.02%
2022-03-31 $1.17B $0.40B 33.70%
2021-12-31 $1.10B $0.37B 33.27%
2021-09-30 $1.02B $0.33B 32.58%
2021-06-30 $0.91B $0.30B 32.42%
2021-03-31 $0.82B $0.27B 32.52%
2020-12-31 $0.79B $0.26B 32.24%
2020-09-30 $0.81B $0.24B 29.40%
2020-06-30 $0.87B $0.24B 27.63%
2020-03-31 $0.92B $0.23B 24.54%
2019-12-31 $0.84B $0.28B 32.93%
2019-09-30 $0.84B $0.31B 36.39%
2019-06-30 $0.83B $0.31B 36.88%
2019-03-31 $0.84B $0.33B 39.40%
2018-12-31 $1.02B $0.34B 32.97%
2018-09-30 $1.06B $0.34B 31.89%
2018-06-30 $1.12B $0.36B 31.94%
2018-03-31 $1.13B $0.36B 32.18%
2017-12-31 $1.14B $0.36B 31.93%
2017-09-30 $1.11B $0.36B 32.43%
2017-06-30 $1.06B $0.35B 32.80%
2017-03-31 $1.03B $0.34B 32.88%
2016-12-31 $0.94B $0.31B 32.56%
2016-09-30 $0.39B $0.28B 71.50%
2016-06-30 $0.52B $0.27B 52.60%
2016-03-31 $0.70B $0.24B 34.24%
2015-12-31 $0.90B $0.27B 29.90%
2015-09-30 $1.72B $0.29B 17.08%
2015-06-30 $1.82B $0.29B 15.81%
2015-03-31 $1.92B $0.35B 18.17%
2014-12-31 $1.97B $0.36B 18.30%
2014-09-30 $1.96B $0.41B 20.78%
2014-06-30 $1.99B $0.46B 23.24%
2014-03-31 $1.95B $0.41B 21.01%
2013-12-31 $1.95B $0.39B 19.73%
2013-09-30 $1.98B $0.41B 20.53%
2013-06-30 $1.97B $0.39B 19.92%
2013-03-31 $1.98B $0.42B 21.27%
2012-12-31 $1.96B $0.36B 18.51%
2012-09-30 $1.78B $0.29B 16.23%
2012-06-30 $1.84B $0.22B 11.88%
2012-03-31 $1.96B $0.21B 10.48%
2011-12-31 $2.00B $0.25B 12.66%
2011-09-30 $2.21B $0.29B 13.16%
2011-06-30 $2.12B $0.35B 16.29%
2011-03-31 $1.96B $0.33B 16.74%
2010-12-31 $1.81B $0.32B 17.49%
2010-09-30 $1.65B $0.26B 15.62%
2010-06-30 $1.44B $0.24B 16.53%
2010-03-31 $1.22B $0.24B 19.22%
2009-12-31 $1.03B $0.20B 19.24%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.110B $1.380B
Hypera S.A. is a pharmaceutical company. It engages in development of pharmaceuticals, dermocosmetics, vitamin supplements, and health products. Hypera serves customers primarily in Latin America. The company was formerly known as Hypermarcas S.A. and is headquartered in Sao Paulo, Brazil.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.521B 32.46
Zoetis (ZTS) United States $75.160B 28.04
Takeda Pharmaceutical (TAK) Japan $48.970B 9.74
Daiichi Sankyo, - (DSNKY) Japan $47.728B 24.46
BeOne Medicines - (ONC) Cayman Islands $30.278B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.478B 0.00
Merck (MKKGY) Germany $17.344B 12.71
Summit Therapeutics (SMMT) United States $14.972B 0.00
Shionogi (SGIOY) Japan $14.530B 14.56
United Therapeutics (UTHR) United States $12.907B 11.42
Neurocrine Biosciences (NBIX) United States $12.372B 42.38
Orion OYJ (ORINY) Finland $10.289B 27.82
IPSEN (IPSEY) France $9.940B 0.00
Corcept Therapeutics (CORT) United States $7.548B 61.36
Stevanato Group S.p.A (STVN) Italy $7.268B 44.44
Madrigal Pharmaceuticals (MDGL) United States $6.599B 0.00
Grifols, S.A (GRFS) Spain $6.174B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.669B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.042B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.012B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.963B 10.38
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
NewAmsterdam Pharma (NAMS) Netherlands $2.361B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.176B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.102B 0.00
Indivior (INDV) United States $1.921B 8.15
Dyne Therapeutics (DYN) United States $1.644B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.608B 0.00
Evotec AG (EVO) Germany $1.577B 0.00
Ocular Therapeutix (OCUL) United States $1.426B 0.00
ARS Pharmaceuticals (SPRY) United States $1.414B 0.00
Guardian Pharmacy Services (GRDN) United States $1.282B 0.00
Harrow (HROW) United States $1.143B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.112B 22.24
Enliven Therapeutics (ELVN) United States $0.965B 0.00
Akebia Therapeutics (AKBA) United States $0.959B 0.00
Collegium Pharmaceutical (COLL) United States $0.951B 5.13
Avadel Pharmaceuticals (AVDL) Ireland $0.904B 0.00
Ardelyx (ARDX) United States $0.890B 0.00
Cronos Group (CRON) Canada $0.768B 0.00
Elite Pharmaceuticals (ELTP) United States $0.735B 0.00
Xeris Biopharma Holdings (XERS) United States $0.691B 0.00
Xencor (XNCR) United States $0.671B 0.00
KalVista Pharmaceuticals (KALV) United States $0.651B 0.00
Relay Therapeutics (RLAY) United States $0.591B 0.00
AleAnna (ANNA) United States $0.586B 0.00
Altimmune (ALT) United States $0.580B 0.00
Verve Therapeutics (VERV) United States $0.563B 0.00
Regulus Therapeutics (RGLS) United States $0.559B 0.00
USANA Health Sciences (USNA) United States $0.555B 12.06
Bioventus (BVS) United States $0.551B 13.98
Theravance Biopharma (TBPH) United States $0.531B 0.00
Liminatus Pharma (LIMN) United States $0.528B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
Tourmaline Bio (TRML) United States $0.511B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
Oruka Therapeutics (ORKA) United States $0.482B 0.00
Siga Technologies (SIGA) United States $0.460B 9.61
Organogenesis (ORGO) United States $0.402B 0.00
Savara (SVRA) United States $0.391B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 10.29
Aquestive Therapeutics (AQST) United States $0.329B 0.00
Heron Therapeutics (HRTX) United States $0.307B 0.00
Nanobiotix S.A (NBTX) France $0.271B 0.00
Nature's Sunshine Products (NATR) United States $0.267B 24.49
ProKidney (PROK) United States $0.262B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.253B 0.00
Esperion Therapeutics (ESPR) United States $0.238B 0.00
MediWound (MDWD) Israel $0.220B 0.00
OmniAb (OABI) United States $0.209B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.190B 0.00
Larimar Therapeutics (LRMR) United States $0.186B 0.00
Aldeyra Therapeutics (ALDX) United States $0.175B 0.00
Aclaris Therapeutics (ACRS) United States $0.166B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.153B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Lyell Immunopharma (LYEL) United States $0.144B 0.00
Inhibikase Therapeutics (IKT) United States $0.142B 0.00
Lexeo Therapeutics (LXEO) United States $0.136B 0.00
Korro Bio (KRRO) United States $0.131B 0.00
Protara Therapeutics (TARA) United States $0.126B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
Cardiol Therapeutics (CRDL) Canada $0.119B 0.00
Achieve Life Sciences (ACHV) Canada $0.115B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.112B 0.00
Nektar Therapeutics (NKTR) United States $0.109B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.108B 0.00
Fractyl Health (GUTS) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.102B 0.00
Champions Oncology (CSBR) United States $0.102B 16.81
Wellgistics Health (WGRX) United States $0.101B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 65.11
Arch Biopartners (ACHFF) Canada $0.088B 0.00
Galectin Therapeutics (GALT) United States $0.085B 0.00
Nutriband (NTRB) United States $0.085B 0.00
Inotiv (NOTV) United States $0.081B 0.00
Surrozen (SRZN) United States $0.080B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Unicycive Therapeutics (UNCY) United States $0.077B 0.00
Pyxis Oncology (PYXS) United States $0.076B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Vivani Medical (VANI) United States $0.071B 0.00
Klotho Neurosciences (KLTO) United States $0.065B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.060B 0.00
NRx Pharmaceuticals (NRXP) United States $0.059B 0.00
Assertio Holdings (ASRT) United States $0.059B 0.00
Prelude Therapeutics (PRLD) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Avalo Therapeutics (AVTX) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
PolyPid (PYPD) Israel $0.035B 0.00
China SXT Pharmaceuticals (SXTC) China $0.032B 0.00
SCYNEXIS (SCYX) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
Carisma Therapeutics (CARM) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
BioVie (BIVI) United States $0.022B 0.00
CASI Pharmaceuticals (CASI) China $0.022B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
Mannatech (MTEX) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.18
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
Citius Pharmaceuticals (CTXR) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00